Randomized trial · people
HGH: liver fat 3.3% lower at 24 weeks vs no treatment, not significant
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In young adults with obesity and fatty liver, growth hormone showed a possible but unconfirmed drop in liver fat, with no clear change in liver enzymes, lipids or blood sugar over 24 weeks.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 24
- Published
- 2021
- Journal
- Clin Endocrinol (Oxf)
What they tested
The team tested whether growth hormone lowers liver fat in young adults with obesity and nonalcoholic fatty liver disease (NAFLD, fat buildup in the liver not caused by alcohol).
How the study was done
A randomized pilot trial in 24 men and women aged 18-29 with a BMI of 30 kg/m2 or more, liver fat of at least 5% on an MRI-based scan, and IGF-1 (a hormone that growth hormone raises) at or below average. They got recombinant human growth hormone or no treatment for 24 weeks, and the main measure was the change in liver fat.

What they found
Compared with no treatment, the growth hormone group's liver fat changed by -3.3% over 24 weeks, but this result was not statistically significant (95% confidence interval -7.8% to 1.2%). At 24 weeks, 5 of 9 people on growth hormone had liver fat below 5%, versus 1 of 9 with no treatment, a statistically significant difference. Liver enzymes ALT, AST and GGT did not drop significantly, and IGF-1 rose as expected. Fasting lipids, C-reactive protein (a marker of inflammation), fasting glucose and 2-hour glucose after a sugar drink test did not change.
What it doesn’t show
This was a small, 24-week pilot study, and its main result was not statistically significant. The comparison group got no treatment rather than a placebo, and larger studies are needed to confirm any effect on liver fat.
The paper
Pan et al. Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2021.
The compound
More studies on HGH
- HGH: long-acting PEG form beat daily HGH on height at 12 monthsMeta-analysis · people · 2025
- HGH: adult burn wounds healed 9.07 days faster in a meta-analysisMeta-analysis · people · 2014
- HGH: weekly Pegpesen matched daily rhGH on growth in childrenRandomized trial · people · 2025
- HGH: 9.78 cm/year growth vs 10.10 on weekly somatrogonRandomized trial · people · 2022
- HGH: weekly somatrogon 9.65 vs daily 7.87 cm/year in GHD childrenRandomized trial · people · 2022
- HGH: MoCA cognition score rose from 16.31 to 21.19 after strokeRandomized trial · people · 2020
- Every study on HGH
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.